| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/19/2006 | EP1646389A1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 04/19/2006 | EP1646382A2 Compounds, compositions and methods |
| 04/19/2006 | EP1513833B1 Novel 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/19/2006 | EP1487801B1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo¬d|azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders |
| 04/19/2006 | EP1472236A4 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide |
| 04/19/2006 | EP1420784B1 Compounds effecting glucokinase |
| 04/19/2006 | EP1401439B1 Use of bicyclo compounds for treating alzheimer's disease |
| 04/19/2006 | EP1387838B1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 04/19/2006 | EP1339695B1 Farnesyltransferase inhibitors |
| 04/19/2006 | EP1317428B1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 04/19/2006 | EP1296959B1 Methods and compositions utilizing quinazolinones |
| 04/19/2006 | EP1253924B1 Nitrate salts of antimicrobial agents |
| 04/19/2006 | EP1189890B1 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 04/19/2006 | EP1177176B1 Tri-aryl acid derivatives as ppar receptor ligands |
| 04/19/2006 | EP1112284B1 Piperazine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p53 |
| 04/19/2006 | EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants |
| 04/19/2006 | EP0901474B1 Aryl pyrimidine derivatives |
| 04/19/2006 | EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 04/19/2006 | EP0859772B1 Herbicidal substituted pyridine compounds |
| 04/19/2006 | CN1761660A Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles |
| 04/19/2006 | CN1761657A EP4 receptor antagonists |
| 04/19/2006 | CN1761646A Cannabinoid receptor ligands |
| 04/19/2006 | CN1761466A Therapeutic and/or preventive agent for chronic skin disease |
| 04/19/2006 | CN1760193A Antifungal compound of alkyl substitutional triazole class |
| 04/19/2006 | CN1252066C Pyridazine-3-one derivatives, their use, and intermediate preparing them |
| 04/19/2006 | CN1251680C Compositions comprising cytosine derivatives for the treatment of cancer |
| 04/18/2006 | US7030246 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof |
| 04/18/2006 | US7030241 Mesylates of piperazine derivatives and process for their preparation |
| 04/18/2006 | US7030150 Benzimidazole compounds and antiviral uses thereof |
| 04/18/2006 | US7030143 Heterocyclic compounds |
| 04/18/2006 | US7030140 such as 1-[1-(N,N-dimethyl-aminoethyl)-1H-benzimidazol-2-ylmethyl]-1H-benzotriazole hydrochloride for treatment of respiratory syncytial virus |
| 04/18/2006 | US7030139 Compounds |
| 04/18/2006 | US7030130 Benzofuran derivatives and their use as antibacterial agents |
| 04/18/2006 | US7030120 Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same |
| 04/18/2006 | US7030117 Sodium channel blockers |
| 04/18/2006 | US7030063 Cyclohexenonquinolinoyl-derivatives as herbicidal agents |
| 04/18/2006 | US7029812 Organophotoreceptor with charge transport compound having an epoxy group |
| 04/18/2006 | CA2273374C Trioxane dimer compounds having antiproliferative and antitumor activities |
| 04/14/2006 | WO2005032544A1 Treatment of mitochondrial diseases |
| 04/14/2006 | CA2580584A1 Use of alpha-tocotrienol for treatment of mitochondrial diseases |
| 04/13/2006 | WO2006039243A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | WO2006039215A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | WO2006038989A1 Substituted arylamides |
| 04/13/2006 | WO2006038972A1 Cci-779 derivatives and methods of making same |
| 04/13/2006 | WO2006038738A1 Receptor function regulating agent |
| 04/13/2006 | WO2006038172A1 New piperidine antibiotics |
| 04/13/2006 | WO2006028958A3 Pyridyl inhibitors of hedgehog signalling |
| 04/13/2006 | WO2005110416A3 4,5-disubstituted-2-aryl pyrimidines |
| 04/13/2006 | WO2005087752A3 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/13/2006 | WO2005082866A3 Substituted 1, 2, 4- triazole derivatives as oxytocin antagonists |
| 04/13/2006 | US20060079697 1-substituted-4-nitroimidazole compound and process for producing the same |
| 04/13/2006 | US20060079693 Method and intermediate for preparing a prostaglandin F-type compound |
| 04/13/2006 | US20060079685 1-(4-Bromo-benzyl)-4-(4-isopropyl-phenyl)-6-propargyloxy-1H-quinazolin-2-one;osteoporosis, bone disorders, fractures, osteopathy, osteo-malacia, periodontal bone loss or bone loss due to arthritis or osteoarthritis; for promoting the release of parathyroid hormone |
| 04/13/2006 | US20060079684 Thrombin receptor antagonists |
| 04/13/2006 | US20060079575 Anticancer agent for drug resistant cancer |
| 04/13/2006 | US20060079572 Novel bioactive substance |
| 04/13/2006 | US20060079554 Inhibitors of monomine uptake |
| 04/13/2006 | US20060079527 Compounds such as 1-[4-(3,4-difluoro-phenyl) -piperazin-1 -yl]-3-{methyl-[2-(9H-xanthen-9-yl)-ethyl]-amino}-propan-1 -one in free base or acid addition salt form, for therapy of depression, anxiety and bipolar disorders |
| 04/13/2006 | US20060079519 Heterocyclic-substituted benzamide derivatives, e.g., benzyl [2-(4-{1-[5-(5-tert-Butyl-3-methanesulfonylamino-2-methoxy-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazol-4-yl}-2-phenyl-2H-pyrazol-3-yl)-ethyl]-carbamate; inhibit production of cytokines; useful for treating chronic inflammatory disease. |
| 04/13/2006 | US20060079518 Such as (S)-4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-3-{6-[4-(2-methoxy-ethyl)-piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl}-1H-pyridin-2-one bis hydrochloride; anticancer agents; antiproliferative agents |
| 04/13/2006 | DE19637425B4 Neue N-Vinyllactam-Derivate und deren Polymere New N-vinyl lactam derivatives and their polymers |
| 04/13/2006 | CA2583326A1 Receptor function regulating agent |
| 04/13/2006 | CA2582356A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | CA2582347A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | CA2581057A1 New piperidine antibiotics |
| 04/13/2006 | CA2577011A1 Cci-779 derivatives and methods of making same |
| 04/12/2006 | EP1645273A2 Novel use of (R)-(-)-2-(5-(-flourophenyl)-3-pyridylmethylaminoethyl|-chromane and its physiologically acceptable salts |
| 04/12/2006 | EP1644393A2 Novel lincomycin derivatives possessing antimicrobial activity |
| 04/12/2006 | EP1644373A1 Tricyclic delta opioid modulators |
| 04/12/2006 | EP1644370A2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/12/2006 | EP1644369A2 Arylamine-substituted quinazolinone compounds |
| 04/12/2006 | EP1644365A2 Pyrazine and pyridine derivatives as rho kinase inhibitors |
| 04/12/2006 | EP1644364A1 Tetrazol benzofurancarboxamides with pi3k activity as therapeutic agents |
| 04/12/2006 | EP1644363A1 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 04/12/2006 | EP1644357A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/12/2006 | EP1644356A1 Substituted 4-amino-1-benzylpiperidine compounds |
| 04/12/2006 | EP1644343A1 5-substituted quinazolinone derivatives |
| 04/12/2006 | EP1644340A1 N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyformamide compounds as metalloproteinase inhibitors |
| 04/12/2006 | EP1644338A1 2, 4, 6-trisubstituted pyrimidine derivatives useful for the treatment of neoplastic and autoimmune diseases |
| 04/12/2006 | EP1644337A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 04/12/2006 | EP1644335A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 04/12/2006 | EP1643988A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors |
| 04/12/2006 | EP1643960A2 Arylsulfonamide derivatives |
| 04/12/2006 | EP1401828B1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 04/12/2006 | EP1358183B1 Cysteine protease inhibitors |
| 04/12/2006 | EP1345920B1 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/12/2006 | EP1336605B1 Substituted phenol derivatives or salts thereof as inhibitors of coagulation factor x |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | EP1003736B1 Substituted 4-benzoyl-pyrazoles |
| 04/12/2006 | CN1759112A Benzimidazole derivatives and their use for modulating the GABA- SB A /SB receptor complex |
| 04/12/2006 | CN1759108A Biphenyl derivatives |
| 04/12/2006 | CN1759101A Quinolinone / benzoxazinone derivatives and uses thereof |
| 04/12/2006 | CN1250542C 2-(1H-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 04/12/2006 | CN1250531C Novel compounds |
| 04/12/2006 | CN1250516C Process for preparation of aniline compounds |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026357 Diphenylurea compounds |
| 04/11/2006 | US7026352 Physiologically active substances |